Full-Time

Director – Research Strategic Planning and Operations

Confirmed live in the last 24 hours

Vir Biotechnology

Vir Biotechnology

501-1,000 employees

Develops monoclonal antibodies for infectious diseases

AI & Machine Learning
Biotechnology

Compensation Overview

$207k - $272kAnnually

Senior, Expert

No H1B Sponsorship

San Francisco, CA, USA

Requires onsite presence in San Francisco for four days per week.

Category
Computational Biology
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Advanced degree (PhD, MD, MBA, or equivalent) in a relevant scientific or business discipline.
  • Minimum of 10+ years of experience in research operations, strategic planning, or a related role within the biotech or pharmaceutical industry.
  • Demonstrated experience in leading large, cross-functional teams and managing complex projects and/or department/enterprise initiatives, and influencing without authority.
  • Ability to independently develop and execute strategic plans, with a proven track record of driving growth and innovation.
  • Deep understanding of research processes, project management, and operational excellence.
  • Strong analytical and problem-solving skills, with a focus on data-driven decision-making.
Responsibilities
  • In partnership with the COO-R, oversee the daily operations of the Research Department, ensuring efficient workflows, establishment of necessary business processes in service of both department and project-related objective.
  • Develop and implement best practices for strategic planning, research project management and operational processes.
  • Monitor and report on department goals to track progress and identify areas for improvement.
  • Establish and maintain an integrated project portfolio for the Research Department.
  • In partnership with the Research Portfolio Committee, CSO Leadership Team, and CSO Strategy Team, conduct regular portfolio reviews, prioritize projects, and make recommendations for resource allocation or project adjustments.
  • Contribute to Research Governance matters, including the Research Portfolio Committee (Chair: CSO), Research Portfolio Reviews, and stage gate matters.
  • In partnership with the COO-R, develop, manage, and monitor the research budget, ensuring alignment with strategic goals and financial constraints.
  • In partnership with the COO-R, identify opportunities for cost savings and operational efficiencies within the Research Department.
  • Build and reinforce relationships and business processes with key internal Partners.
  • Represent the Research Department in cross-functional meetings and initiatives.
  • Contribute to the management of ongoing external research institution and academic partnerships.
  • In partnership with COO-R, mentor and develop a high-performing team of research project team leads to support research governance and stage gate progression.
  • Foster a collaborative team culture that aligns with the company’s values and mission.
  • Implement development programs to enhance team capabilities.
  • Foster a culture of innovation within the Research Department by implementing advanced technologies, methodologies, and best practices.
  • Lead continuous improvement initiatives to enhance research productivity, efficiency, and quality.

Vir Biotechnology develops treatments for infectious diseases by harnessing the immune system, using a proprietary platform for monoclonal antibodies (mAbs) combined with machine learning and artificial intelligence. Their pipeline includes clinical candidates for hepatitis B, hepatitis delta, and HIV, as well as monoclonal antibodies targeting influenza, COVID-19, and human papillomavirus. What distinguishes Vir from competitors is its collaboration with industry leaders and organizations to expedite scientific advancements. The company's goal is to transform lives by addressing unmet medical needs.

Company Stage

Grant

Total Funding

$640.6M

Headquarters

San Francisco, California

Founded

2016

Growth & Insights
Headcount

6 month growth

2%

1 year growth

5%

2 year growth

8%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent bullish quarterly reports and increased analyst estimates suggest strong financial performance.
  • Significant investments, such as the $214,000 from Diversified Trust Co, indicate confidence in Vir's future prospects.
  • Presentations at high-profile conferences like J.P. Morgan's Annual Healthcare Conference and AASLD's The Liver Meeting® enhance Vir's visibility and credibility in the biotech community.

What critics are saying

  • Recent layoffs and facility shutdowns indicate potential financial instability and operational challenges.
  • The resignation of key executives, including the CFO and Chief Medical Officer, could lead to strategic and leadership uncertainties.

What makes Vir Biotechnology unique

  • Vir Biotechnology's focus on leveraging immunology expertise to engineer human antibodies into powerful medicines sets it apart from competitors.
  • Their rapid growth, as evidenced by being ranked the fastest-growing company in North America on the 2023 Deloitte Technology Fast 500, highlights their market impact.
  • Vir's ongoing Phase 2 trials for chronic hepatitis delta and B demonstrate their commitment to addressing unmet medical needs with innovative therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive healthcare coverage

Employer matched 401(k)

Employee stock purchase plan

Childcare assistance

Tuition reimbursement